4//SEC Filing
Vivo Opportunity, LLC 4
Accession 0001213900-24-074051
CIK 0001484565other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 7:36 PM ET
Size
12.3 KB
Accession
0001213900-24-074051
Insider Transaction Report
Form 4
Vivo Opportunity, LLC
10% Owner
Transactions
- Sale
Common Stock
2024-08-27$48.73/sh−500,000$24,365,000→ 6,816,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.) - Sale
Common Stock
2024-08-28$47.35/sh−425,000$20,123,750→ 6,391,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.) - Sale
Common Stock
2024-08-29$47.22/sh−100,000$4,722,000→ 6,291,851 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Footnotes (4)
- [F1]Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- [F2]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $47.00 to $51.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $46.79 to $48.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $46.47 to $47.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4.
Documents
Issuer
SOLENO THERAPEUTICS INC
CIK 0001484565
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001728970
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 7:36 PM ET
- Size
- 12.3 KB